A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx

NCT02055989 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Larynx, Hypopharyngeal Squamous Cell Cancers
Locally Advanced Thyroid Cancers

Interventions

RADIATION: Dose-escalated radiotherapy level 1
RADIATION: Sequential dose-escalated radiotherapy level 2

Sponsor

Royal Marsden NHS Foundation Trust